113 results on '"scratching behavior"'
Search Results
102. Possível efeito analgésico da vigabatrina na dor neuropática crônica experimental animal
- Author
-
Alba Maria Pinho de Carvalho, Franklin J. C. Santos, Nilza Dutra Alves, Delano G. Silveira, and Carlos Maurício de Castro-Costa
- Subjects
Phenytoin ,genetic structures ,experimental ,Analgesic ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Vigabatrin ,thermal tests ,scratching behavior ,Animals ,Medicine ,Rats, Wistar ,comportamento de coçar-se ,neuropathic pain ,Analgesics ,Valproic Acid ,business.industry ,dor neuropática ,analgesia ,Carbamazepine ,Scratching ,testes térmicos ,Rats ,ratos Wistar ,nervous system diseases ,Wistar rats ,vigabatrina ,Neurology ,Opioid ,Anesthesia ,Chronic Disease ,Neuropathic pain ,Neuralgia ,Anticonvulsants ,Neurology (clinical) ,business ,vigabatrin ,medicine.drug ,RC321-571 - Abstract
Since anticonvulsants have been used for treating neuralgias, an interest has arisen to experimentally test vigabatrin for its gabaergic mechanism of action. For this, 41 Wistar rats were used, and in 25 of them a constrictive sciatic neuropathy was induced (Bennet & Xie model). For testing pain symptoms, spontaneous (scratching) and evoked behaviors to noxious (46o C) and non-noxious (40o C) thermal stimuli were quantified. Moreover, a comparative pharmacological study of vigabatrin with other analgesic anticonvulsant drugs was also performed. The results showed a possible dose-dependent analgesic effect of vigabatrin (gamma-vinyl-GABA) on experimental neuropathic pain, as shown by the significant (p
- Published
- 1999
103. Possible analgesic effect of vigabatrin in animal experimental chronic neuropathic pain
- Author
-
ALVES NILZA D., CASTRO-COSTA CARLOS M. DE, CARVALHO ALBA M. DE, SANTOS FRANKLIN J. C., and SILVEIRA DELANO G.
- Subjects
neuropathic pain ,Wistar rats ,genetic structures ,experimental ,thermal tests ,scratching behavior ,analgesia ,vigabatrin ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,nervous system diseases ,lcsh:RC321-571 - Abstract
Since anticonvulsants have been used for treating neuralgias, an interest has arisen to experimentally test vigabatrin for its gabaergic mechanism of action. For this, 41 Wistar rats were used, and in 25 of them a constrictive sciatic neuropathy was induced (Bennet & Xie model). For testing pain symptoms, spontaneous (scratching) and evoked behaviors to noxious (46o C) and non-noxious (40o C) thermal stimuli were quantified. Moreover, a comparative pharmacological study of vigabatrin with other analgesic anticonvulsant drugs was also performed. The results showed a possible dose-dependent analgesic effect of vigabatrin (gamma-vinyl-GABA) on experimental neuropathic pain, as shown by the significant (p
- Published
- 1999
104. Soybean Fermented with Bacillus amyloliquefaciens (Cheonggukjang) Ameliorates Atopic Dermatitis-Like Skin Lesion in Mice by Suppressing Infiltration of Mast Cells and Production of IL-31 Cytokine.
- Author
-
Cho BO, Shin JY, Kim JS, Che DN, Kang HJ, Jeong DY, and Jang SI
- Subjects
- Animals, Cytokines metabolism, Dermatitis, Atopic pathology, Disease Models, Animal, Focal Epithelial Hyperplasia drug therapy, Focal Epithelial Hyperplasia pathology, Immunoglobulin E blood, Male, Mice, Republic of Korea, Skin pathology, Skin Diseases pathology, Bacillus amyloliquefaciens metabolism, Dermatitis, Atopic drug therapy, Fermented Foods, Interleukins metabolism, Mast Cells drug effects, Plant Extracts pharmacology, Skin Diseases drug therapy, Glycine max metabolism
- Abstract
The present study was conducted with the aim to investigate the ameliorative effects of a new soybean product (cheonggukjang) fermented with Bacillus amyloliquefaciens SCGB1 (SFBA) in atopic dermatitis (AD) mouse model. Visual evaluation of AD induction in the mice indicated the remarkable control of SFBA in reducing the pathological severity of AD-like skin lesions reported as the SCORAD score of AD clinical symptoms. The results revealed that SFBA reduced dorsal skin and epidermal thickness to a similar extent with prednisolone. Further analysis revealed the dominance of SFBA in restraining mast cell infiltration in the dermis; immunoglobulin-E expression in serum; and TH2 IL-4 cytokine and itch-related IL-31 cytokine in the mice skin and serum. SFBA also suppressed scratching behaviours in mice induced by compound 48/80. Further histological findings also revealed the alleviation of collagen fiber deposition in dermal skin of the AD mice model. These actions of SFBA were examined to be mediated by its suppression of the phosphorylation activation of key signalling molecules such as NF-kappaB and MAPK responsible for the induction of cytokine production. Thus, SFBA can be considered as a promising functional food for managing clinical, histological and immunological spectra associated with AD.
- Published
- 2019
- Full Text
- View/download PDF
105. Neural processing of itch
- Author
-
Earl Carstens and Tasuku Akiyama
- Subjects
H1R ,GRPR ,toll-like receptor 7 ,two-pore-domain potassium channels ,IL-31 ,Rho rock ,5-HT2 ,spinothalamic tract ,transient receptor potential vanilloid 1 ,Psychology ,toll-like receptor 3 ,NK-1 ,Neurons ,NGF ,voltage-gated potassium channel ,Pain Research ,isolectin B4 ,Nppb ,Analgesics, Opioid ,Spinal Cord ,Neural processing ,endothelin-1 ,GRP ,Cognitive Sciences ,LTP ,Mrgpr ,nociceptive specific ,Chronic Pain ,BAM8–22 ,Opioid ,TRPA1 ,Article ,LTB4 receptor ,G protein-coupled bile acid receptor 1 ,Humans ,Neurons, Afferent ,Interleukin 31 ,low threshold ,Animal ,K2P ,OSMR ,TXA2 ,Gastrin-releasing peptide receptor ,morphine receptor-1D isoform ,5 hydroxytryptamine serotonin ,Npra ,ET-1 ,Electrophysiological Phenomena ,bovine adrenal medullary peptide 8–22 ,Neuroscience ,substance P ,5-HT ,thromboxane A2 ,natriuretic polypeptide B ,ETA-1 ,STT ,Natriuretic peptide receptor A ,AITC ,Kv ,LT ,WDR ,endothelin receptor A-1 ,itch ,TLR3 ,Chronic itch ,TLR7 ,Neurotransmitter Agents ,Analgesics ,natriuretic peptide receptor A ,5-HT receptor subtype 2 ,SP ,General Neuroscience ,TGR5 ,leukotriene B4 ,allyl isothiocyanate ,LPA ,transient receptor potential ankyrin 1 ,trigeminal caudalis ,IB4 ,LTB4 ,Neurological ,LTMRs ,mechanically insensitive ,Opioid analgesics ,Signal Transduction ,neurokinin-1 receptor ,protease-activated receptor ,dorsal root ganglion ,histamine receptor-1 ,low-threshold mechanoreceptors ,BLT ,VGLUT2 ,Rho-ROCK ,wide dynamic range ,NS ,Rho-associated protein kinase ,5-hydroxytryptamine ,nerve growth factor ,Vc ,Interneurons ,scratching behavior ,Vesicular Glutamate Transporter 2 ,Animals ,testicular orphan nuclear receptor-4 ,Trigeminal Nerve ,vesicular glutamate transporter-2 ,long-term potentiation ,MI ,Mas-related G-protein-coupled receptor ,Neurology & Neurosurgery ,Pruritus ,trigeminal subnucleus caudalis ,Neurosciences ,PAF ,PAG ,TR4 ,sphingosylphosphorylcholine ,Afferent ,MOR1D ,oncostatin M receptor ,pruritogens ,Gastrin-releasing peptide ,TRPV1 ,Disease Models, Animal ,DRG ,Platelet-activating factor ,periaqueductal gray ,Disease Models ,SPC ,Isolectin b4 ,PAR ,lysophosphatidic acid - Abstract
While considerable effort has been made to investigate the neural mechanisms of pain, much less effort has been devoted to itch, at least until recently. However, itch is now gaining increasing recognition as a widespread and costly medical and socioeconomic issue. This is accompanied by increasing interest in the underlying neural mechanisms of itch, which has become a vibrant and rapidly-advancing field of research. The goal of the present forefront review is to describe the recent progress that has been made in our understanding of itch mechanisms.
- Published
- 2013
106. Scratching behaviour and its features: a questionnaire-based study in an Italian sample of domestic cats
- Author
-
Patrick Pageat, Angelo Gazzano, Manuel Mengoli, Alessandro Cozzi, Elisa Cestarollo, Céline Lafont-Lecuelle, and Chiara Mariti
- Subjects
Male ,Population ,cat ,Sample (statistics) ,scratching behavior ,Chemical communication ,Ethogram ,Multiple correspondence analysis ,Animals ,Small Animals ,education ,education.field_of_study ,CATS ,Models, Statistical ,integumentary system ,Behavior, Animal ,Data Collection ,Scratching ,eye diseases ,Neutering ,Italy ,Cats ,Female ,Psychology ,Clinical psychology - Abstract
Scratching behaviour in cats is described as a normal expression of the feline ethogram, having different possible purposes related to visual and chemical communication. During behavioural consultations owners often mention scratching as an additional problem. This preliminary study aimed to understand the characteristics of this complex behaviour by examining the variables displayed by a sample of the Italian feline population using multiple correspondence analysis. One hundred and twenty-eight cats were screened by means of a questionnaire to identify features of their scratching behaviour. Our data showed the importance of both the presence/absence of a scratching post in the cat’s living area and its relationship to marking. When a scratching post is present in a cat’s living area, the cat appears to use it. Some aspects related to sex, neutering, age and environmental characteristics may modify the expression of scratching as a marking behaviour. Research has led to increased knowledge of this behaviour and may help veterinarians in describing to owners why it is important for cats to express scratching behaviour in their environment. Such information could help veterinarians and owners to recognise normal and problematic scratching behaviours.
- Published
- 2013
107. SCH23390, a dopamine D1 receptor antagonist, suppressed scratching behavior induced by compound 48/80 in mice
- Author
-
Yoriko Akimoto and Mitsuhiro Furuse
- Subjects
c-fos ,Male ,medicine.medical_specialty ,medicine.drug_class ,chemistry.chemical_compound ,Mice ,Dopamine receptor D1 ,SCH23390 ,Dopamine ,Internal medicine ,medicine ,Compound 48/80 ,Animals ,p-Methoxy-N-methylphenethylamine ,Receptor ,Pharmacology ,Mice, Inbred ICR ,Behavior, Animal ,Receptors, Dopamine D2 ,Receptors, Dopamine D1 ,Dopaminergic ,Antagonist ,Brain ,Scratching behavior ,Antipruritics ,Scratching ,Benzazepines ,Receptor antagonist ,Protein Transport ,Endocrinology ,chemistry ,Proto-Oncogene Proteins c-fos ,medicine.drug - Abstract
To clarify the mechanisms by which compound 48/80 (C48/80) induces scratching behavior, the involvement of dopamine D(1) receptors was investigated. The intracisternal (i.t.) administration of SCH23390 (1.0 μg), a selective dopamine D(1) receptor antagonist, significantly decreased C48/80-induced scratching behavior in mice. These results suggest that dopamine D(1) receptors contribute to scratching behavior or the itch sensation induced by subcutaneous injection of C48/80 in mice. Co-administration of SCH23390 and C48/80 enhanced c-fos immunoreactivities in the peduncular part of the lateral hypothalamus (PLH), whereas the immunoreactivities in the other groups were unchanged. The dopaminergic system may be playing an important role in the suppression of C48/80-induced scratching behavior by SCH23390.
- Published
- 2011
108. 第65回東邦医学会総会シンポジウム:皮膚からみた心,精神からみた肌 精神科の意見を聞きたい皮膚科症例:アトピー性皮膚炎の1例
- Author
-
鷲崎, 久美子 and 鷲崎, 久美子
- Abstract
総説, アトピー性皮膚炎の経過には心理社会的要因が関与することが明らかとなり,2009 年版日本皮膚科学会による「アトピー性皮膚炎診療ガイドライン」にも基本的治療のひとつとして心身医学的側面からの治療が明記された.今回,39 歳,男性,通院は不定期で増悪により当科入院となったアトピー性皮膚炎患者につき検討した.本例は悪化時のみの受診,治療への意欲がない等から,アトピー性皮膚炎における心身症の分類では「治療・管理への不適応」に相当すると考える.客観評価では抑うつやストレスはなかったが,共感の過程で家族,仕事のストレスが判明し自身が掻破行動との関連を自覚するに至った.これら心身医学的側面からの評価・加療と,痒みに対する行動療法,生活や外用療法指導,疾患に関する知識の教育を行い,2 週間で軽快退院となった.アトピー性皮膚炎加療にあたり,時には精神科医のアドバイスを求めながら,心身医学的治療を行う必要性は高いと考えた.
- Published
- 2012
109. The effect of feline interdigital semiochemicals with primers in relation to scratching marking.
- Author
-
Pageat, P., Bougrat, L., Monneret, P., Alnot-Perronin, M., and Cozzi, A.
- Published
- 2010
- Full Text
- View/download PDF
110. Bee venom ameliorates compound 48/80-induced atopic dermatitis-related symptoms.
- Author
-
Kim KH, Lee WR, An HJ, Kim JY, Chung H, Han SM, Lee ML, Lee KG, Pak SC, and Park KK
- Subjects
- Animals, Anti-Inflammatory Agents administration & dosage, Antipruritics administration & dosage, Bee Venoms administration & dosage, Capillary Permeability drug effects, Cell Degranulation drug effects, Cytokines metabolism, Dermatitis, Atopic chemically induced, Dermatitis, Atopic immunology, Dermatitis, Atopic metabolism, Disease Models, Animal, Inflammation Mediators metabolism, Injections, Intraperitoneal, Male, Mast Cells drug effects, Mast Cells immunology, Mast Cells metabolism, Mice, Mice, Inbred BALB C, Pruritus chemically induced, Pruritus immunology, Pruritus metabolism, Anti-Inflammatory Agents pharmacology, Antipruritics pharmacology, Bee Venoms pharmacology, Dermatitis, Atopic drug therapy, Pruritus drug therapy, p-Methoxy-N-methylphenethylamine
- Abstract
Unlabelled: Honeybee (Apis mellifera L.) venom (BV) has been traditionally used for the treatment of pain and inflammatory diseases such as itchy skin problems. However, the precise mechanism of BV in ameliorating the scratching behavior is not fully understood., Objective: In order to evaluate the effect of BV on atopic dermatitis-related symptoms in mice, we used a mouse skin scratching model induced by compound 48/80. The anti-itch effect of BV was investigated in a compound 48/80-induced mouse scratching behavior model. BALB/c mice were injected intraperitoneally with vehicle (saline 0.9%) or BV (0.01 and 0.1 mg/kg). One hour after treatment, the animals received a subcutaneous injection of compound 48/80. Intraperitoneal administration of BV (0.01 and 0.1 mg/kg) attenuated compound 48/80-induced scratching behaviors. The anti-scratching behavior effect of BV was in proportional to its vascular permeability effects. Treatment with BV also inhibited the degranulation of mast cells and the production of pro-inflammatory cytokines in compound 48/80-treated skin tissues. According to these results, BV may improve atopic dermatitis-related symptoms by inhibiting the mast cell degranulation and pro-inflammatory cytokine expression.
- Published
- 2013
111. アトピー性皮膚炎モデルにおける掻痒調節機構と掻痒治療薬に関する研究
- Author
-
千葉大学大学院薬学研究院
- Subjects
NC/Nga mice ,掻破行動 ,掻痒 ,痒み ,IL-31 ,Scratching behavior ,Prostanoid DP1 receptor ,ProstaglandinD2 ,494.8 ,Itch ,アトピー性皮膚炎 ,TS-022 ,Atopic dermatitis - Abstract
研究科: 千葉大学大学院薬学研究院, 修了年:2007, 学位:千大院医薬博乙第医薬9号
112. OLOPATADINE HYDROCHLORIDE INHIBITS SCRATCHING BEHAVIOR INDUCED BY A PROTEINASE-ACTIVATED RECEPTOR 2 AGONIST IN MICE
- Author
-
Ayumi Yoshizaki and Shinichi Sato
- Subjects
Agonist ,Time Factors ,medicine.drug_class ,Preprotachykinin a ,Substance P ,Dermatology ,Pharmacology ,Biochemistry ,Mice ,chemistry.chemical_compound ,Tachykinins ,medicine ,Animals ,Receptor, PAR-2 ,Protease-activated receptor ,RNA, Messenger ,Protein Precursors ,Receptor ,Olopatadine hydrochloride ,Molecular Biology ,Behavior, Animal ,Dose-Response Relationship, Drug ,business.industry ,Pruritus ,Preprotachykinin A ,Scratching behavior ,Antipruritics ,Scratching ,Olopatadine Hydrochloride ,Mice, Inbred C57BL ,Disease Models, Animal ,chemistry ,business ,Oligopeptides ,Dibenzoxepins ,Proteinase-activated receptors - Abstract
Title Olopatadine hydrochloride inhibits scratching behavior induced by a proteinase-activated receptor 2 agonist in mice. Author(s) Yoshizaki, Ayumi; Sato, Shinichi Citation Journal of dermatological science, 56(2), pp.136-139; 2009 Issue Date 2009-11 URL http://hdl.handle.net/10069/22311 Right Copyright © 2009 Japanese Society for Investigative Dermatology Published by Elsevier Ireland Ltd. NAOSITE: Nagasaki University's Academic Output SITE
113. アトピー性皮膚炎モデルにおける掻痒調節機構と掻痒治療薬に関する研究
- Author
-
千葉大学大学院薬学研究院
- Subjects
NC/Nga mice ,掻破行動 ,掻痒 ,痒み ,IL-31 ,Scratching behavior ,Prostanoid DP1 receptor ,ProstaglandinD2 ,494.8 ,Itch ,アトピー性皮膚炎 ,TS-022 ,Atopic dermatitis - Abstract
研究科: 千葉大学大学院薬学研究院, 修了年:2007, 学位:千大院医薬博乙第医薬9号
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.